undamentalytics Newsletter
Sign in

Procept Biorobotics Corp balance sheet

At the end of fiscal 2025, Procept Biorobotics Corp had total assets of $508m, total liabilities of $142m and shareholders' equity of $366m. It held $287m in cash against $52.0m of debt: net cash of $235m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents100304222257334287228
Receivables2415488384108
Inventory7132940567177
Total current assets110326273351482450420
Total assets126337309405534508479
Accounts payable12913101715
Deferred revenue (current)0136101314
Total current liabilities15163546536664
Short-term debt50—————
Long-term debt44505151515252
Total debt50505252525252
Total liabilities6570112124132142139
Shareholders' equity−183267197281402366340
Non-controlling interests and other (assets − liabilities − equity)244——————
Net debt (negative = net cash)−50−254−170−205−282−235−176
Shares outstanding——45m51m55m56m57m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: PRCT vs STAAANGO vs PRCTINGN vs PRCT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Procept Biorobotics Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Procept Biorobotics Corp.